Cover Image
市場調查報告書

日本的血液凝固檢查市場新境界:商務方面的課題,新技術,競爭環境

2018 Japan Coagulation Market: Supplier Sales and Shares, Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Landscape

出版商 Venture Planning Group 商品編碼 301134
出版日期 內容資訊 英文 402 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
日本的血液凝固檢查市場新境界:商務方面的課題,新技術,競爭環境 2018 Japan Coagulation Market: Supplier Sales and Shares, Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Landscape
出版日期: 內容資訊: 英文 402 Pages
簡介

本報告提供日本的血液凝固檢查相關市場最新趨勢和今後的市場機會相關分析,彙整日本市場整體市場規模和未來趨勢(今後5年份),目前診斷技術的概要與今後的技術進步·有效利用預測,今後的市場機會及應該解決的課題,現在/未來市場參與企業簡介等調查,並將結果概述為以下內容。

第1章 簡介

第2章 全球市場及技術概要

  • 主要的血液凝固檢查(例行檢查·特別檢驗)
    • 簡介
    • APTT(部分活血凝酶時間)
    • α2抗纖維蛋白分解酵素
    • 抗凝血酵素III
    • 出血時間
    • D-Dimer
    • 乙醇凝血檢驗
    • 優球蛋白溶解
    • 因子試驗(全12種)
    • 纖維蛋白分解物
    • 纖維蛋白原
    • 肝素
    • 水蛭素
    • 高凝血狀態以及血栓症
    • 脂蛋白A
    • 血漿素
    • 血漿素原
    • 血漿素原活性化因子阻礙要素(PAI)
    • 血小板功能檢查
    • 血小板凝集
    • 蛋白質C&S
    • 凝血酵素碎片1.2
    • 凝血酵素原時間(PT)
    • 蛇毒素試驗時間
    • 凝血時間
    • t-PA(組織纖維蛋白原活性化因子)
    • Von Willebrand' s因子
  • 各種設備的檢討
  • 主要的體外診斷技術潛在的用途
    • 分子診斷
    • 呈色受質
    • 單株抗體和多株抗體
    • 免疫分析
    • 微電腦
    • 自動化
    • 機器人技術
    • 人工智能
    • 乾式化學分析
    • 生物感應器

第3章 日本市場

  • 摘要整理
  • 商業環境
  • 市場結構
  • 市場規模·成長率,主要供應商的銷售額與市場佔有率

第4章 主要的產品開發機會

第5章 分散檢驗產品的設計標準

第6章 替代性的打入市場策略

  • 內部開發
  • 協動產業協定
  • 與大學的契約
  • 分散檢驗市場流通策略
    • 行銷的方法
    • 產品的複雜性
    • 客戶的偏好
    • 既有廠商
    • 新加入廠商
    • 主要種類的流通業者
    • 市場分類

第7章 加入市場的潛在障礙與風險

  • 市場的成熟度
  • 成本控制
  • 競爭
  • 技術的限制
  • 專利保護
  • 法規的限制
  • 分散檢驗市場課題

第8章 競爭企業的評估

  • Abbott
  • ADI/American Diagnostic
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC/Nexus Dx
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • ZyCare/Alere

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: VPCO30423

Complete report $7,400.  DataPack (test volumes, sales forecasts, supplier shares) $4,800.

VPGMarketResearch’s new report is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the Japanese coagulation testing market during the next five years.

The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the Japanese coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Japanese Market Overview

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.

- Estimated universe of facilities performing coagulation tests.

- Five-year test volume and sales projections.

Business Opportunities and Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.

- “Ideal” product models with tentative prices and operating characteristics.

- Alternative market penetration strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

Current and Emerging Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis of Instrument and Reagent Suppliers

- Sales and market shares of major instrument and consumable manufactures.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including:

     - Hospitals      - Commercial/Private Laboratories

- Test volume forecasts for over 40 major procedures, by market segment.

Current and Emerging Products

- Review of established and new procedures.

- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Roche, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative coagulation testing technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

     - Abbott      - ADI/American Diagnostica      - Alere/Biosite/Inverness      - Axis-Shield      - Beckman Coulter/Danaher      - Becton Dickinson      - Bio/Data      - Chrono-Log      - Corgenix Medical      - Diagnostica Stago/Trinity Biotech      - Grifols      - Helena Laboratories      - Hyphen BioMed      - Instrumentation Laboratory      - ITC/Nexus Dx      - Roche      - Siemens      - Sienco      - Sysmex      - Thermo Fisher      - ZyCare/Alere

Contains 402 pages and 35 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Routine and Special Coagulation Tests
    • 1. Introduction
    • 2. Activated Partial Thromboplastin Time (APTT)
    • 3. Alpha-2 Antiplasmin
    • 4. Antithrombin III
    • 5. Bleeding Time
    • 6. D-Dimer
    • 7. Ethanol Flocculation Test
    • 8. Euglobulin Lysis
    • 9. Factor Assays
      • a. Introduction
      • b. Factor II
      • c. Factor V/Factor V Leiden
      • d. Factor VII
      • e. Factor VIII
      • f. Factor IX
      • g. Factor IXa
      • h. Factor X (Stuart Factor)
      • i. Factor Xa
      • j. Factor XI
      • k. Factor XII
      • l. Factor XIII
    • 10. Fibrin Degradation Products
    • 11. Fibrinogen
    • 12. Heparin
    • 13. Hirudin
    • 14. Hypercoagulability and Thrombosis
    • 15. Lipoprotein a
    • 16. Plasmin
    • 17. Plasminogen
    • 18. Plasminogen Activator Inhibitor (PAI)
    • 19. Platelet Function Tests
    • 20. Platelet Aggregation
    • 21. Proteins C and S
    • 22. Prothrombin Fragment 1.2
    • 23. Prothrombin Time (PT)
    • 24. Reptilase Time
    • 25. Thrombin Time
    • 26. Tissue-Type Plasminogen Activator (t-PA)
    • 27. Von Willebrand's Factor
  • B. Instrumentation Review
  • C. Major in Vitro Diagnostic Technologies and Their Potential Applications
    • 1. Molecular Diagnostics
      • a. Technology Overview
      • b. Amplification Methods
      • c. Sequencing
      • d. Microarrays/Biochips
    • 2. Chromogenic Substrates
    • 3. Monoclonal and Polyclonal Antibodies
    • 4. Immunoassays
    • 5. Microcomputers
    • 6. Automation
    • 7. Robotics
    • 8. Artificial Intelligence
    • 9. Dry Chemistry
    • 10. Biosensors

III. Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Instrument and Reagent Suppliers' Sales and Market Shares

IV. Major Product Development Opportunities

V. Design Criteria For Decentralized Testing Products

VI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

VII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

  • Abbott
  • ADI/American Diagnostic
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC/Nexus Dx
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • ZyCare/Alere

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Executive Summary Table: Japan, Total Coagulation Diagnostics Market By Market Segment and Product Category
  • Japan, Laboratories Performing Coagulation Tests By Market Segment
  • Japan, Hospital Laboratories Performing Coagulation Tests By Bed Size
  • Japan, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
  • Japan, Hospital Laboratories Average Daily Test Volume
  • Japan, Commercial/Private Laboratories Average Daily Test Volume
  • Japan, Total Coagulation Test Volume By Market Segment
  • Japan, All Market Segments Coagulation Test Volume
  • Japan, Hospital Laboratories Coagulation Test Volume
  • Japan, Commercial/Private Laboratories Coagulation Test Volume
  • Japan, Coagulation Reagent Market By Market Segment,
  • Japan, Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
  • Japan, Coagulation Instrument Market By Market Segment
  • Japan, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
  • Japan, Total Coagulation Diagnostics Market By Product Category
  • Japan, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Back to Top